Report cover image

Europe Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Drug, By Dosage, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Sales Channel, By Product, By Country and Growth Forec

Publisher Knowledge Based Value (KBV) Research
Published Sep 30, 2022
Length 143 Pages
SKU # KBV17478087

Description

Europe Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Drug, By Dosage, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Sales Channel, By Product, By Country and Growth Forecast, 2022 - 2028

The Europe Dry Eye Syndrome Treatment Market would witness market growth of 3.9% CAGR during the forecast period (2022-2028).

The cause of symptoms usually determines how to treat dry eye. Several alternative types of treatment are available to help and maintain the health of the eyes. Artificial tears are one such treatment option that is most frequently used to treat mild dry eyes. Additionally, some over-the-counter moisturizing gels and balms could provide some relief for the eyes. The eye doctor might prescribe lifitegrast (Xiidra) or cyclosporine (Restasis) if the dry eye condition is more severe. Both of these medications are eye drops that encourage the eyes to produce more tears.

The doctor could recommend modifications to help protect the eyes if something in life or the environment is causing or exacerbating dry eye. If tears are evaporating too quickly, the doctor may advise inserting punctal plugs into tear ducts. These plugs can block tears from running out of the eyes. When lower eyelids have become too slack, tears may drain from the eyes too quickly, which can lead to dry eyes. An eye doctor may recommend surgery to repair eyelids and assist tears to stay on the eyes if it is the reason for dry eye.

In Europe, between 11% and 30% of persons have dry eye illnesses. The population is aging and expanding, and more youth are being diagnosed as a result of increased screen usage, particularly as a result of the COVID-19 pandemic. Dry eye illness requires more attention. Key concerns include diagnosis and management, which present difficulties for both patients and their doctors. There are currently a variety of various diagnostic and therapeutic methods for the management of dry eye disease in Europe. For instance, several nations, like Germany, have already developed recommendations for the use of anti-inflammatory medication in the treatment of dry eye illness. These factors would escalate the growth of the regional market during the forecast period.

The Germany market dominated the Europe Dry Eye Syndrome Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $414.9 million by 2028. The UK market is exhibiting a CAGR of 3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 4.6% during (2022 - 2028).

Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drug, the market is segmented into Restasis, Xiidra, Cequa, Eysuvis and Tyrvaya & Others. Based on Dosage, the market is segmented into Eye drops, Gels, Capsules & Tablets, Eye Solutions and Ointments. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Sales Channel, the market is segmented into OTC and Prescription. Based on Product, the market is segmented into Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Services, Inc.), AbbVie, Inc., Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Novartis AG, Sun Pharmaceuticals Industries Ltd., AFT Pharmaceuticals, Santen Pharmaceutical Co., Ltd., Oyster Point Pharma, Inc., OASIS Medical, Inc., and Otsuka Pharmaceutical Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Evaporative Dry Eye Syndrome
  • Aqueous Deficient Dry Eye Syndrome
By Drug
  • Restasis
  • Xiidra
  • Cequa
  • Eysuvis
  • Tyrvaya & Others
By Dosage
  • Eye drops
  • Gels
  • Capsules & Tablets
  • Eye Solutions
  • Ointments
By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
By Sales Channel
  • OTC
  • Prescription
By Product
  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
  • Oral Omega Supplements
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • AbbVie, Inc.
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Novartis AG
  • Sun Pharmaceuticals Industries Ltd.
  • AFT Pharmaceuticals
  • Santen Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

143 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Dry Eye Syndrome Treatment Market, by Type
1.4.2 Europe Dry Eye Syndrome Treatment Market, by Drug
1.4.3 Europe Dry Eye Syndrome Treatment Market, by Dosage
1.4.4 Europe Dry Eye Syndrome Treatment Market, by Distribution Channel
1.4.5 Europe Dry Eye Syndrome Treatment Market, by Sales Channel
1.4.6 Europe Dry Eye Syndrome Treatment Market, by Product
1.4.7 Europe Dry Eye Syndrome Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Dry Eye Syndrome Treatment Market by Type
4.1 Europe Evaporative Dry Eye Syndrome Market by Country
4.2 Europe Aqueous Deficient Dry Eye Syndrome Market by Country
Chapter 5. Europe Dry Eye Syndrome Treatment Market by Drug
5.1 Europe Restasis Market by Country
5.2 Europe Xiidra Market by Country
5.3 Europe Cequa Market by Country
5.4 Europe Eysuvis Market by Country
5.5 Europe Tyrvaya & Others Market by Country
Chapter 6. Europe Dry Eye Syndrome Treatment Market by Dosage
6.1 Europe Eye drops Market by Country
6.2 Europe Gels Market by Country
6.3 Europe Capsules & Tablets Market by Country
6.4 Europe Eye Solutions Market by Country
6.5 Europe Ointments Market by Country
Chapter 7. Europe Dry Eye Syndrome Treatment Market by Distribution Channel
7.1 Europe Retail Pharmacy Market by Country
7.2 Europe Hospital Pharmacy Market by Country
7.3 Europe Online Pharmacy Market by Country
Chapter 8. Europe Dry Eye Syndrome Treatment Market by Sales Channel
8.1 Europe OTC Market by Country
8.2 Europe Prescription Market by Country
Chapter 9. Europe Dry Eye Syndrome Treatment Market by Product
9.1 Europe Cyclosporine Market by Country
9.2 Europe Topical Corticosteroids Market by Country
9.3 Europe Artificial Tears Market by Country
9.4 Europe Punctal Plugs Market by Country
9.5 Europe Oral Omega Supplements Market by Country
9.6 Europe Others Market by Country
Chapter 10. Europe Dry Eye Syndrome Treatment Market by Country
10.1 Germany Dry Eye Syndrome Treatment Market
10.1.1 Germany Dry Eye Syndrome Treatment Market by Type
10.1.2 Germany Dry Eye Syndrome Treatment Market by Drug
10.1.3 Germany Dry Eye Syndrome Treatment Market by Dosage
10.1.4 Germany Dry Eye Syndrome Treatment Market by Distribution Channel
10.1.5 Germany Dry Eye Syndrome Treatment Market by Sales Channel
10.1.6 Germany Dry Eye Syndrome Treatment Market by Product
10.2 UK Dry Eye Syndrome Treatment Market
10.2.1 UK Dry Eye Syndrome Treatment Market by Type
10.2.2 UK Dry Eye Syndrome Treatment Market by Drug
10.2.3 UK Dry Eye Syndrome Treatment Market by Dosage
10.2.4 UK Dry Eye Syndrome Treatment Market by Distribution Channel
10.2.5 UK Dry Eye Syndrome Treatment Market by Sales Channel
10.2.6 UK Dry Eye Syndrome Treatment Market by Product
10.3 France Dry Eye Syndrome Treatment Market
10.3.1 France Dry Eye Syndrome Treatment Market by Type
10.3.2 France Dry Eye Syndrome Treatment Market by Drug
10.3.3 France Dry Eye Syndrome Treatment Market by Dosage
10.3.4 France Dry Eye Syndrome Treatment Market by Distribution Channel
10.3.5 France Dry Eye Syndrome Treatment Market by Sales Channel
10.3.6 France Dry Eye Syndrome Treatment Market by Product
10.4 Russia Dry Eye Syndrome Treatment Market
10.4.1 Russia Dry Eye Syndrome Treatment Market by Type
10.4.2 Russia Dry Eye Syndrome Treatment Market by Drug
10.4.3 Russia Dry Eye Syndrome Treatment Market by Dosage
10.4.4 Russia Dry Eye Syndrome Treatment Market by Distribution Channel
10.4.5 Russia Dry Eye Syndrome Treatment Market by Sales Channel
10.4.6 Russia Dry Eye Syndrome Treatment Market by Product
10.5 Spain Dry Eye Syndrome Treatment Market
10.5.1 Spain Dry Eye Syndrome Treatment Market by Type
10.5.2 Spain Dry Eye Syndrome Treatment Market by Drug
10.5.3 Spain Dry Eye Syndrome Treatment Market by Dosage
10.5.4 Spain Dry Eye Syndrome Treatment Market by Distribution Channel
10.5.5 Spain Dry Eye Syndrome Treatment Market by Sales Channel
10.5.6 Spain Dry Eye Syndrome Treatment Market by Product
10.6 Italy Dry Eye Syndrome Treatment Market
10.6.1 Italy Dry Eye Syndrome Treatment Market by Type
10.6.2 Italy Dry Eye Syndrome Treatment Market by Drug
10.6.3 Italy Dry Eye Syndrome Treatment Market by Dosage
10.6.4 Italy Dry Eye Syndrome Treatment Market by Distribution Channel
10.6.5 Italy Dry Eye Syndrome Treatment Market by Sales Channel
10.6.6 Italy Dry Eye Syndrome Treatment Market by Product
10.7 Rest of Europe Dry Eye Syndrome Treatment Market
10.7.1 Rest of Europe Dry Eye Syndrome Treatment Market by Type
10.7.2 Rest of Europe Dry Eye Syndrome Treatment Market by Drug
10.7.3 Rest of Europe Dry Eye Syndrome Treatment Market by Dosage
10.7.4 Rest of Europe Dry Eye Syndrome Treatment Market by Distribution Channel
10.7.5 Rest of Europe Dry Eye Syndrome Treatment Market by Sales Channel
10.7.6 Rest of Europe Dry Eye Syndrome Treatment Market by Product
Chapter 11. Company Profiles
11.1 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental &Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Product Launches and Product Expansions:
11.1.5.2 Approvals and Trials:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.3 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Sun Pharmaceuticals Industries Ltd
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Product Launches and Product Expansions:
11.5.5.2 Approvals and Trials:
11.6 AFT Pharmaceuticals
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Product Launches and Product Expansions:
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.5.2 Approvals and Trials:
11.8 Oyster Point Pharma, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Research & Development Expenses
11.8.4 Recent strategies and developments:
11.8.4.1 Partnerships, Collaborations, and Agreements:
11.8.4.2 Approvals and Trials:
11.9 OASIS Medical, Inc.
11.9.1 Company Overview
11.9.2 Recent strategies and developments:
11.9.2.1 Product Launches and Product Expansions:
11.10. Otsuka Pharmaceutical Co., Ltd.
11.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us